Publicacions en col·laboració amb investigadors/es de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (55)

2024

  1. Correction to: Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation (Diabetologia, (2022), 65, 8, (1375-1389), 10.1007/s00125-022-05729-y)

    Diabetologia

  2. Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy

    CANCER DRUG RESISTANCE, Vol. 7

2023

  1. Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer’s disease and brain aging

    Journal of Neuroinflammation, Vol. 20, Núm. 1

  2. Pharmacological activation of insulin-degrading enzyme improves insulin secretion and glucose tolerance in diet-induced obese mice

    Diabetes, Obesity and Metabolism, Vol. 25, Núm. 11, pp. 3268-3278

  3. rMSIfragment: improving MALDI-MSI lipidomics through automated in-source fragment annotation

    Journal of Cheminformatics, Vol. 15, Núm. 1

2022

  1. Association between genetic variants in oxidative stress-related genes and osteoporotic bone fracture. The Hortega follow-up study

    Gene, Vol. 809

  2. Evolutionary Origin of Insulin-Degrading Enzyme and Its Subcellular Localization and Secretion Mechanism: A Study in Microglial Cells

    Cells, Vol. 11, Núm. 2

  3. Genetic variants in obesity-related genes and the risk of osteoporotic fracture. The Hortega Follow-up Study

    Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 1, pp. 32

  4. Insulin receptor activation by proinsulin preserves synapses and vision in retinitis pigmentosa

    Cell Death and Disease, Vol. 13, Núm. 4

  5. Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation

    Diabetologia, Vol. 65, Núm. 8, pp. 1375-1389

  6. Phosphorylation of cPLA2 α at Ser505 Is Necessary for Its Translocation to PtdInsP2-Enriched Membranes

    Molecules, Vol. 27, Núm. 7

  7. Primary Cilia in Pancreatic β- and α-Cells: Time to Revisit the Role of Insulin-Degrading Enzyme

    Frontiers in Endocrinology, Vol. 13

2021

  1. Effects of fasting and feeding on transcriptional and posttranscriptional regulation of insulin‐degrading enzyme in mice

    Cells, Vol. 10, Núm. 9

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Lipin-1-derived diacylglycerol activates intracellular TRPC3 which is critical for inflammatory signaling

    Cellular and Molecular Life Sciences, Vol. 78, Núm. 24, pp. 8243-8260

  4. Mitochondrial cristae-remodeling protein OPA1 in POMC neurons couples Ca2+ homeostasis with adipose tissue lipolysis

    Cell Metabolism, Vol. 33, Núm. 9, pp. 1820-1835.e9

  5. Modulation of insulin sensitivity by insulin-degrading enzyme

    Biomedicines, Vol. 9, Núm. 1, pp. 1-38

  6. P38γ and p38δ regulate postnatal cardiac metabolism through glycogen synthase 1

    PLoS Biology, Vol. 19, Núm. 11

  7. miR-126 contributes to the epigenetic signature of diabetic vascular smooth muscle and enhances antirestenosis effects of Kv1.3 blockers

    Molecular Metabolism, Vol. 53

2020

  1. C3G contributes to platelet activation and aggregation by regulating major signaling pathways

    Signal Transduction and Targeted Therapy, Vol. 5, Núm. 1